Sep 1 2010

Burger King’s Post-I.P.O. Stock Price Isn’t Royal

As Burger King holds talks with prospective buyers, including Brazilian-backed 3G Capital, it’s worth looking at how the buyout-backed fast food giant has performed since going public again in 2006. The answer: not well at all, especially compared with arch rival McDonald’s. Excluding the jump in Burger King’s stock price on Wednesday, thanks to reports [...]


Sep 1 2010

What Price Is Right for Genzyme?

The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]


Sep 1 2010

What Price Is Right for Genzyme?

The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]


Sep 1 2010

What Price Is Right for Genzyme?

The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]


Aug 26 2010

Rick Scott Lags Behind Alex Sink in Florida Governor Race, Paying Price for Divisive Primary

Former health care executive Rick Scott paid a price for his free-spending, no-holds-barred victory in Florida’s gubernatorial primary as he starts out the general election campaign with high personal negatives and running behind Democrat Alex Sink, according to a Public Policy Polling survey conducted Aug. 21-22. Sink, the state’s chief financial officer, leads Scott by [...]


Aug 24 2010

Sanofi-Genzyme Talks Said to Stall on Price

Talks between the French pharmaceutical giant Sanofi-Aventis and the American biotech company Genzyme have hit a snag as the two sides try to agree on a threshhold price that would allow Sanofi to proceed with due diligence, The Wall Street Journal reports. Sanofi shareholders have signaled that they are reluctant to see their offer rise [...]